Herd-level association between antimicrobial use and antimicrobial resistance in bovine mastitis Staphylococcus aureus isolates on Canadian dairy farms

被引:79
作者
Saini, V. [1 ,2 ]
McClure, J. T. [2 ,3 ]
Scholl, D. T. [2 ,4 ]
DeVries, T. J. [2 ,5 ]
Barkema, H. W. [1 ,2 ,6 ]
机构
[1] Univ Calgary, Dept Prod Anim Hlth, Calgary, AB T2N 4N1, Canada
[2] Canadian Bovine Mastitis Res Network, St Hyacinthe, PQ J2S 7C6, Canada
[3] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Charlottetown, PE C1A 4P3, Canada
[4] Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, St Hyacinthe, PQ J2S 7C6, Canada
[5] Univ Guelph, Dept Anim & Poultry Sci, Kemptville, ON K0G 1J0, Canada
[6] Univ Ghent, Dept Reprod Obstet & Herd Hlth, Merelbeke, Belgium
关键词
antimicrobial resistance; antimicrobial use; mastitis; Staphylococcus aureus; CLINICAL MASTITIS; INTRAMAMMARY INFECTIONS; MANAGEMENT-PRACTICES; SUSCEPTIBILITY; PATHOGENS; MILK; COWS; PREVALENCE; PENICILLIN; LACTATION;
D O I
10.3168/jds.2011-5065
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Surveillance of antimicrobial use and resistance is needed to manage antimicrobial resistance in bacteria. In this study, data were collected on antimicrobial use and resistance in Staphylococcus aureus (n = 562), isolated from intramammary infections and (sub)clinical mastitis cases on 89 dairy farms in 4 regions of Canada [Alberta, Ontario, Quebec, and the Maritime Provinces (Prince Edward Island, Nova Scotia, and New Brunswick)]. Dairy producers were asked to deposit empty drug containers into specially provided receptacles, and antimicrobial drug use rate was calculated to quantify antimicrobial use. Minimum inhibitory concentrations were determined using the Sensititer bovine mastitis plate system (TREK Diagnostic Systems Inc., Cleveland, OH), containing antimicrobials commonly used for mastitis treatment and control. Multivariable logistic regression models were built to determine herd-level risk factors of penicillin, ampicillin, pirlimycin, penicillin-novobiocin combination, tetracycline and sulfadimethoxine resistance in Staph. aureus isolates. Intramammary administration of the penicillin-novobiocin combination for dry cow therapy was associated with penicillin and ampicillin resistance [odds ratio (OR): 2.17 and 3.10, respectively]. Systemic administration of penicillin was associated with penicillin resistance (OR: 1.63). Intramammary administration of pirlimycin for lactating cow mastitis treatment was associated with pirlimycin resistance as well (OR: 2.07). Average herd parity was associated with ampicillin and tetracycline resistance (OR: 3.88 and 0.02, respectively). Average herd size was also associated with tetracycline resistance (OR: 1.02). Dairy herds in the Maritime region had higher odds of penicillin and lower odds of ampicillin resistance than dairy herds in Quebec (OR: 2.18 and 0.19, respectively). Alberta dairy herds had lower odds of ampicillin and sulfadimethoxine resistance than dairy herds in Quebec (OR: 0.04 and 0.08, respectively). Ontario dairy herds had lower odds of tetracycline and sulfadimethoxine resistance than dairy herds in Quebec (OR: 0.05 and 0.33, respectively). Herd-level use of certain antimicrobials administered for mastitis treatment and control, such as intramammary penicillin and pirlimycin as well as systemically administered penicillin and florfenicol, was positively associated with antimicrobial resistance in bovine mastitis pathogens in the field conditions. Differences in antimicrobial resistance outcomes across 4 regions of Canada were observed.
引用
收藏
页码:1921 / 1929
页数:9
相关论文
共 45 条
[1]   Antimicrobial resistance at farm level [J].
Acar, J. F. ;
Moulin, G. .
REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES, 2006, 25 (02) :775-792
[2]  
[Anonymous], 2008, CLSI document M31-A3, V28, P65
[3]  
Baggot J.D., 2006, Antimicrobial therapy in veterinary medicine, P65
[4]   Invited review:: The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis [J].
Barkema, H. W. ;
Schukken, Y. H. ;
Zadoks, R. N. .
JOURNAL OF DAIRY SCIENCE, 2006, 89 (06) :1877-1895
[5]   Management practices associated with the incidence rate of clinical mastitis [J].
Barkema, HW ;
Schukken, YH ;
Lam, TJGM ;
Beiboer, ML ;
Benedictus, G ;
Brand, A .
JOURNAL OF DAIRY SCIENCE, 1999, 82 (08) :1643-1654
[6]   Incidence of clinical mastitis in dairy herds grouped in three categories by bulk milk somatic cell counts [J].
Barkema, HW ;
Schukken, YH ;
Lam, TJGM ;
Beiboer, ML ;
Wilmink, H ;
Benedictus, G ;
Brand, A .
JOURNAL OF DAIRY SCIENCE, 1998, 81 (02) :411-419
[7]  
Dohoo IR, 2009, VET EPIDEMIOLOGIC RE
[8]   Mastitis therapy and pharmacology [J].
Erskine, RJ ;
Wagner, S ;
DeGraves, FJ .
VETERINARY CLINICS OF NORTH AMERICA-FOOD ANIMAL PRACTICE, 2003, 19 (01) :109-+
[9]   Trends in antibacterial susceptibility of mastitis pathogens during a seven-year period [J].
Erskine, RJ ;
Walker, RD ;
Bolin, CA ;
Bartlett, PC ;
White, DG .
JOURNAL OF DAIRY SCIENCE, 2002, 85 (05) :1111-1118
[10]  
Finnish Food Authority FINRES-Vet, 2021, FINN VET ANT RES MON